Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

IL8 and IL16 levels indicate serum and plasma quality

IL8 and IL16 levels indicate serum and plasma quality AbstractBackground:Longer pre-centrifugation times alter the quality of serum and plasma samples. Markers for such delays in sample processing and hence for the sample quality, have been identified.Methods:Twenty cytokines in serum, EDTA plasma and citrate plasma samples were screened for changes in concentration induced by extended blood pre-centrifugation delays at room temperature. The two cytokines that showed the largest changes were further validated for their “diagnostic performance” in identifying serum or plasma samples with extended pre-centrifugation times.Results:In this study, using R&D Systems ELISA kits, EDTA plasma samples and serum samples with a pre-centrifugation delay longer than 24 h had an IL16 concentration higher than 313 pg/mL, and an IL8 concentration higher than 125 pg/mL, respectively. EDTA plasma samples with a pre-centrifugation delay longer than 48 h had an IL16 concentration higher than 897 pg/mL, citrate plasma samples had an IL8 concentration higher than 21.5 pg/mL and serum samples had an IL8 concentration higher than 528 pg/mL.Conclusions:These robust and accurate tools, based on simple and commercially available ELISA assays can greatly facilitate qualification of serum and plasma legacy collections with undocumented pre-analytics. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Chemistry and Laboratory Medicine (CCLM) de Gruyter

IL8 and IL16 levels indicate serum and plasma quality

Download PDF
9 pages
Read Article

Loading next page...
 
/lp/degruyter/il8-and-il16-levels-indicate-serum-and-plasma-quality-pcSv9c9SSn
Publisher
de Gruyter
Copyright
©2018 Fay Betsou et al., published by De Gruyter, Berlin/Boston
ISSN
1437-4331
eISSN
1437-4331
DOI
10.1515/cclm-2017-1047
Publisher site
See Article on Publisher Site

Abstract

AbstractBackground:Longer pre-centrifugation times alter the quality of serum and plasma samples. Markers for such delays in sample processing and hence for the sample quality, have been identified.Methods:Twenty cytokines in serum, EDTA plasma and citrate plasma samples were screened for changes in concentration induced by extended blood pre-centrifugation delays at room temperature. The two cytokines that showed the largest changes were further validated for their “diagnostic performance” in identifying serum or plasma samples with extended pre-centrifugation times.Results:In this study, using R&D Systems ELISA kits, EDTA plasma samples and serum samples with a pre-centrifugation delay longer than 24 h had an IL16 concentration higher than 313 pg/mL, and an IL8 concentration higher than 125 pg/mL, respectively. EDTA plasma samples with a pre-centrifugation delay longer than 48 h had an IL16 concentration higher than 897 pg/mL, citrate plasma samples had an IL8 concentration higher than 21.5 pg/mL and serum samples had an IL8 concentration higher than 528 pg/mL.Conclusions:These robust and accurate tools, based on simple and commercially available ELISA assays can greatly facilitate qualification of serum and plasma legacy collections with undocumented pre-analytics.

Journal

Clinical Chemistry and Laboratory Medicine (CCLM) – de Gruyter

Published: Jun 27, 2018

References

  • Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction
  • Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?
  • Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis
  • Serum concentrations of interleukin-8 in relation to different levels of alcohol consumption
  • Effects of storage time and exogenous protease inhibitors on plasma protein levels
  • Storage of serum or whole blood samples? Effects of time and temperature on 22 serum analytes
  • Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects
  • Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group
  • Cytokine levels in the serum of healthy subjects
  • Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC)
  • A biospecimen proficiency testing program for biobank accreditation: four years of experience
  • Cytokine levels in the serum of healthy subjects
  • A review on interleukins: the key manipulators in rheumatoid arthritis
  • Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects
  • Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group
  • Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock
  • Stability studies of twenty-four analytes in human plasma and serum
  • LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic aceid levels
  • Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC)
  • Chemokines and chemokine receptors: positioning cells for host defense and immunity
  • Interleukin-16 serum levels during the course of HIV-1 infection
  • Variables that affect assays for plasma cytokines and soluble activation markers
  • Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis
  • Elevated plasma levels of interleukin-12p40 and interleukin-16 in overweight adolescents
  • Effects of storage time and exogenous protease inhibitors on plasma protein levels
  • Chemokines and chemokine receptors: positioning cells for host defense and immunity
  • Determination of total interleukin-8 in whole blood after cell lysis
  • Interleukin-16 serum levels during the course of HIV-1 infection
  • Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8
  • Assays for qualification and quality stratification of clinical biospecimens used in research: a technical report from the ISBER Biospecimen Science Working Group
  • Impact of whole-blood processing conditions on plasma and serum concentrations of cytokines
  • Interleukin-16 expression in the peripheral blood and CD8 T lymphocytes after traumatic injury
  • Adhesive interaction between peripheral blood mononuclear cells and activated platelets in the presence of anti-human leukocyte antigen Class I alloantibody causes production of IL-1β and IL-8
  • Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling
  • Interleukin-16
  • Pre-analytical operating procedures for serum low molecular weight protein profiling
  • Impact of whole-blood processing conditions on plasma and serum concentrations of cytokines
  • Stability studies of twenty-four analytes in human plasma and serum
  • Standard preanalytical coding for biospecimens: defining the sample PREanalytical code
  • Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum
  • Soluble CD40 ligand as a biomarker for storage-related preanalytic variations of human serum
  • A biospecimen proficiency testing program for biobank accreditation: four years of experience
  • Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling
  • Storage of serum or whole blood samples? Effects of time and temperature on 22 serum analytes
  • Cytokines and organ failure in acute pancreatitis: inflammatory response in acute pancreatitis
  • Elevated plasma levels of interleukin-12p40 and interleukin-16 in overweight adolescents
  • Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis
  • Variables that affect assays for plasma cytokines and soluble activation markers
  • Serum concentrations of interleukin-8 in relation to different levels of alcohol consumption
  • Interleukin-16 expression in the peripheral blood and CD8 T lymphocytes after traumatic injury
  • Interleukin-16
  • Pre-analytical operating procedures for serum low molecular weight protein profiling
  • Assays for qualification and quality stratification of clinical biospecimens used in research: a technical report from the ISBER Biospecimen Science Working Group
  • Determination of total interleukin-8 in whole blood after cell lysis
  • A review on interleukins: the key manipulators in rheumatoid arthritis
  • Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice?
  • Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock
  • Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction
  • Standard preanalytical coding for biospecimens: defining the sample PREanalytical code
  • LacaScore: a novel plasma sample quality control tool based on ascorbic acid and lactic aceid levels